316 related articles for article (PubMed ID: 17478491)
1. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
3. Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia.
Bonomini M; Dottori S; Amoroso L; Arduini A; Sirolli V
J Thromb Haemost; 2004 Aug; 2(8):1275-81. PubMed ID: 15304031
[TBL] [Abstract][Full Text] [Related]
4. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
5. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
6. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
7. Caspase inhibition decreases both platelet phosphatidylserine exposure and aggregation: caspase inhibition of platelets.
Cohen Z; Wilson J; Ritter L; McDonagh P
Thromb Res; 2004; 113(6):387-93. PubMed ID: 15226093
[TBL] [Abstract][Full Text] [Related]
8. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
9. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
[TBL] [Abstract][Full Text] [Related]
11. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
12. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets.
Rand ML; Wang H; Bang KW; Teitel JM; Blanchette VS; Freedman J; Nurden AT
Am J Hematol; 2010 Aug; 85(8):584-92. PubMed ID: 20658588
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
16. Effects of ebelactone B on cathepsin A activity in intact platelets and on platelet activation.
Ostrowska H; Dabrowska M; Osada J; Mantur M
Rocz Akad Med Bialymst; 2003; 48():150-3. PubMed ID: 14737963
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization.
Wang Y; Beck W; Deppisch R; Marshall SM; Hoenich NA; Thompson MG
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F220-8. PubMed ID: 17670899
[TBL] [Abstract][Full Text] [Related]
18. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
[TBL] [Abstract][Full Text] [Related]
19. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
20. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
